ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Myriad Genetics Inc

Myriad Genetics Inc (0K3W)

35.68
0.00
(0.00%)
Closed 06 January 3:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
35.68
Bid
0.00
Offer
0.00
Volume
0.00
0.00 Day's Range 0.00
35.68 52 Week Range 35.68
Market Cap
Previous Close
35.68
Open
-
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
616
Shares Outstanding
82,198,000
Dividend Yield
-
PE Ratio
-4.27
Earnings Per Share (EPS)
-3.2
Revenue
753.2M
Net Profit
-263.3M

About Myriad Genetics Inc

Sector
In Vitro,in Vivo Diagnostics
Industry
In Vitro,in Vivo Diagnostics
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Myriad Genetics Inc is listed in the In Vitro,in Vivo Diagnostics sector of the London Stock Exchange with ticker 0K3W. The last closing price for Myriad Genetics was US$35.68. Over the last year, Myriad Genetics shares have traded in a share price range of US$ 35.68 to US$ 35.68.

Myriad Genetics currently has 82,198,000 shares in issue. The market capitalisation of Myriad Genetics is US$2.93 billion. Myriad Genetics has a price to earnings ratio (PE ratio) of -4.27.

0K3W Latest News

Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries

Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries New sponsored testing program leverages Myriad’s MyChoice Tests for patients with high-grade serous ovarian...

Nuevo estudio publicado en Clinical Cancer Research Journal destaca el uso de la prueba EndoPredict para informar el tratamiento en pacientes premenopáusicas con cáncer de mama

Nuevo estudio publicado en Clinical Cancer Research Journal destaca el uso de la prueba EndoPredict para informar el tratamiento en pacientes premenopáusicas con cáncer de mama La prueba...

Myriad Genetics s'associe à l'Institut für Hämopathologie Hamburg et au Centre Georges-François Leclerc pour étendre l'accès aux tests génétiques en Europe

Myriad Genetics s'associe à l'Institut für Hämopathologie Hamburg et au Centre Georges-François Leclerc pour étendre l'accès aux tests génétiques en Europe Cette collaboration...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10035.6835.6835.6833835.68DE
40035.6835.6835.6846035.68DE
120035.6835.6835.6861635.68DE
260035.6835.6835.6834735.68DE
520035.6835.6835.6824635.68DE
1560035.6835.6835.6810635.68DE
2600035.6835.6835.687535.68DE

0K3W - Frequently Asked Questions (FAQ)

What is the current Myriad Genetics share price?
The current share price of Myriad Genetics is US$ 35.68
How many Myriad Genetics shares are in issue?
Myriad Genetics has 82,198,000 shares in issue
What is the market cap of Myriad Genetics?
The market capitalisation of Myriad Genetics is USD 2.93B
What is the 1 year trading range for Myriad Genetics share price?
Myriad Genetics has traded in the range of US$ 35.68 to US$ 35.68 during the past year
What is the PE ratio of Myriad Genetics?
The price to earnings ratio of Myriad Genetics is -4.27
What is the cash to sales ratio of Myriad Genetics?
The cash to sales ratio of Myriad Genetics is 1.49
What is the reporting currency for Myriad Genetics?
Myriad Genetics reports financial results in USD
What is the latest annual turnover for Myriad Genetics?
The latest annual turnover of Myriad Genetics is USD 753.2M
What is the latest annual profit for Myriad Genetics?
The latest annual profit of Myriad Genetics is USD -263.3M
What is the registered address of Myriad Genetics?
The registered address for Myriad Genetics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Myriad Genetics website address?
The website address for Myriad Genetics is www.myriad.com
Which industry sector does Myriad Genetics operate in?
Myriad Genetics operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
NeoSunTzu NeoSunTzu 3 minutes ago
It becomes EXREMELY TIRESOME to fully detail EVERY SINGLE DAMN POINT about this story which has a million data points to speak of. My point is they will HIGHLY LIKELY NOT get put back on the NYSE while under c'ship UNLESS our boys want to make an explicit point. Additionally, trading on the NYSE und
zerosnoop zerosnoop 4 minutes ago
Lets see if any of these paid bashers, naked shorters or compulsive liar's bother to show up at the shareholders meeting in February to ask any questions. Common sense tells me these uneducated fools with a low IQ, cowards, grubs & keyboard warriors will stay hiding in their basement hah hah hah
QSEP
236T568 236T568 4 minutes ago
Yikes
https://x.com/visegrad24/status/1876118192168599586?s=19
3331 3331 4 minutes ago
I have Staelin penned as a masterful business strategist. He MUST have a plan.
GetSeriousOK, post #
BIEL
Loudanepro Loudanepro 5 minutes ago
Here are some of them; I’m sure you’ll recognize some of the aliases

https://www.sec.gov/newsroom/press-releases/2022-221
TTCM
Merv77 Merv77 5 minutes ago
fFIE Looks like a short squeeze happening soon ? 
joyceschoice joyceschoice 5 minutes ago
Good point. Let's see if the mods delete this post.
LEHNQ
Merv77 Merv77 6 minutes ago
FFIR stock to look at 
marcis marcis 6 minutes ago
Dude they voted to have the 2024 fins buy the end of April

You make a bogus claim

And the SEC had it’s audit guidelines changed just on Dec15

Next
RDAR
MartinLutherKing MartinLutherKing 8 minutes ago
Do you think the CEo fitzgerald and all his nobel lab rats in management are pocketed investors money while they sabotage the cure to cancer
timberwolf7 timberwolf7 8 minutes ago
TNXP presentation dated 2 Jan 2025. Slide 45 has a 'timeline' listing...

https://d1io3yog0oux5.cloudfront.net/_d620cad351857eb785bc6984eeac7786/tonixpharma/db/211/4414/pdf/Tonix+Short+Investor+Presentation+01.02.25+v1.pdf
TNXP
nowwhat2 nowwhat2 9 minutes ago
WHY SO HARD DROP RIGHT BACK DOWN ?........

https://investorshub.advfn.com/uimage/uploads/2025/1/5/ckgzmtotal_!_5_CAPT_7pm_XRP_RESIST.jpg




https://investorshub.advfn.com/uimage/uploads/2025/1/5/ouvwitotal_!_5_3m_7pm_RESIST.jpg

4Leaf 4Leaf 9 minutes ago
Hey guys. I found this link on Amazon. Crazy that you can't buy now. Hmm. One has to wonder how can Amazon do thiis, meaning how can they offer a product on their platform that no one can buy. Maybe they are still updating the listing. SMH. Yall know what's up. Any insight on this? Link below. 
AITX
Monroe1 Monroe1 10 minutes ago
Wish we were in the running here. With all the knife throwing going on lately, we should at least make them!!

Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives
December 20 2024 - 9:00AM
InvestorsHu
CAFI
MartinLutherKing MartinLutherKing 10 minutes ago
What if they get green light for fast track status
zerosnoop zerosnoop 10 minutes ago
YES. The latest news release clearly states "CONTRACTS have been issued". This must mean waiting for sign offs. The PROVEN AOT is going GLOBAL. Tic toc tic toc.

Expansion into Global Markets

Over the past year, QS Energy has made notable strides in deploying its Applied
QSEP
NeoSunTzu NeoSunTzu 15 minutes ago
I would like to caution and implore everyone to be as proactive and vocal as possible in fighting against the full execution of the warrants. Everyone is giddy and light-headed now with all the rosy financial scenarios and the fact that we have an ostensibly "pro-shareholder" team coming into office
FNMA
Rocky3 Rocky3 15 minutes ago
Let's all admit the truth that Enta made some real bad decisions and then caught a real bad break.

In my view, the worst break was the pricing decision by ABBV in HCV. The market was cut significantly by the decision to compete on price. It killed the receipts for both ABBV and GILD
ABBV
renaissance1 renaissance1 15 minutes ago
Can you post the link to the Instagram post by chance? If not no worries. TIA. HAPPY NEW YEAR TO YOU AS WELL.
GIFX
HoldEm777 HoldEm777 17 minutes ago
This isn’t audited and doubt seriously it ever will be. What about that low interest line of credit? I have yet to hear about it. Thanks
RDAR
Top Penny Top Penny 19 minutes ago
Kim Halvorson Owner of more than 5% Marysville,
Washington
800,000,000 Common 5.3%
PSRU
Shawonsarker84 Shawonsarker84 19 minutes ago
I think the market will push it this week. I noticed 5.7B restricted hasn't changed since Dec 27th. LFG

The Best Part of the New #HMBL
is that it's NOT $HMBL.

$TSNP 1.0

$TSNP 2.0 -> $HMBL

$TSNP 3.0 -> $FinCapital

One
FINCAPITAL HMBL SMX
nowwhat2 nowwhat2 19 minutes ago
WHY SO HARD DROP RIGHT BACK DOWN ?........

https://investorshub.advfn.com/uimage/uploads/2025/1/5/ckgzmtotal_!_5_CAPT_7pm_XRP_RESIST.jpg




https://investorshub.advfn.com/uimage/uploads/2025/1/5/ouvwitotal_!_5_3m_7pm_RESIST.jpg

BTCUSD
New money98 New money98 21 minutes ago
Great..Now provide the agreements that were reached between the secured creditors and Visolis...
marcis marcis 21 minutes ago
No
Do your own research
RDAR

Your Recent History

Delayed Upgrade Clock